Shanxi C&Y Pharmaceutical Group Co Ltd (300254) — Cash Flow-to-Debt Ratio
Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥52.93 Million could theoretically repay 0% of its total liabilities (CN¥972.67 Million) in one year. See 300254 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanxi C&Y Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Shanxi C&Y Pharmaceutical Group Co Ltd across 17 annual periods. Also explore 300254 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2024)
Year-by-year debt coverage analysis for Shanxi C&Y Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see market value of Shanxi C&Y Pharmaceutical Group Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | CN¥70.94 Million | CN¥949.55 Million | ▲ +29.3% |
| 2023 | 0.06x | CN¥37.81 Million | CN¥654.64 Million | ▼ -34.1% |
| 2022 | 0.09x | CN¥74.88 Million | CN¥854.64 Million | ▼ -29.3% |
| 2021 | 0.12x | CN¥96.92 Million | CN¥782.23 Million | ▲ +650.7% |
| 2020 | -0.02x | CN¥-20.88 Million | CN¥927.91 Million | ▼ -128.1% |
| 2019 | 0.08x | CN¥69.63 Million | CN¥869.43 Million | ▲ +17.6% |
| 2018 | 0.07x | CN¥38.44 Million | CN¥564.47 Million | ▼ -7.0% |
| 2017 | 0.07x | CN¥40.10 Million | CN¥547.42 Million | ▼ -16.0% |
| 2016 | 0.09x | CN¥41.65 Million | CN¥477.74 Million | ▲ +146.1% |
| 2015 | 0.04x | CN¥15.44 Million | CN¥435.93 Million | ▼ -84.6% |
| 2014 | 0.23x | CN¥82.19 Million | CN¥358.17 Million | ▼ -8.0% |
| 2013 | 0.25x | CN¥80.58 Million | CN¥323.21 Million | ▲ +25.2% |
| 2012 | 0.20x | CN¥35.05 Million | CN¥175.99 Million | ▲ +409.0% |
| 2011 | 0.04x | CN¥4.75 Million | CN¥121.39 Million | ▼ -90.1% |
| 2010 | 0.40x | CN¥52.03 Million | CN¥131.25 Million | ▼ -46.7% |
| 2009 | 0.74x | CN¥105.55 Million | CN¥141.91 Million | ▲ +323.1% |
| 2008 | -0.33x | CN¥-39.16 Million | CN¥117.45 Million | — |